HHS Report Finds More than 1200 Drugs Raised Prices Quicker than Inflation…
A recent report published by the United States Department of Health and Human Services (HHS) found that more than 1,200…
Author
JAMA Study Analyzes Inequity in Industry Engagement of US Female Physicians
On September 28, 2022, JAMA Surgery published an article, “Assessment of Medical Industry Compensation to US Physicians by…
DOJ Announces $45 Million Settlement with EHR Vendor Over False Claims Act…
On November 1, 2022, the United States Department of Justice (DOJ) announced a $45 million settlement with Modernizing Medicine,…
DOJ and OIG Turn Focus to Corporate Integrity Agreements
On September 15, 2022, Lisa Monaco, Deputy Attorney General of the United States, issued a Memorandum focused on “further…
Providers Call on Congress to Extend APM Incentive Payments
On September 28, 2022, more than 800 organizations and physician practices signed a letter to Congressional leadership, requesting…
DOJ Continues to Prosecute False Claims Act Cases
Under President Joe Biden, the Department of Justice (DOJ) is aggressively pursuing False Claims Act cases in the healthcare…
Who Does the 340B Program Benefit?
Recently, Robert Popovian and Peter J. Pitts authored an editorial for the Food and Drug Law Institute, “340B and the Warped…
Do Private Equity Acquisitions Increase Healthcare Spending and Patient…
A recent study published in JAMA Health Forum found that private equity acquisitions of physician practices were associated with…
DOJ Announces Nearly $8 Million Settlement with Akorn, Resolving False…
In mid-September 2022, the United States Department of Justice (DOJ) announced a $7.9 million settlement with Akorn Operating…
New England Dermatology Office Fined for Improper PHI Disclosure
Earlier this year, the United States Department of Health and Human Services Office for Civil Rights (HHS OCR) announced the…